Role of tesmin expression in non‑small cell lung cancer

Grzegrzolka,Jedrzej; Olbromski,Mateusz; Gomulkiewicz,Agnieszka; Piotrowska,Aleksandra; Glatzel‑Plucinska,Natalia; Ratajczak,Katarzyna; Sputa‑Grzegrzolka,Patrycja; Rzechonek,Adam; Werynska,Bozena; Podhorska‑Okolow,Marzena; Dziegiel,Piotr

doi:10.3892/ol.2020.12309

Role of tesmin expression in non‑small cell lung cancer

Authors:
- Jedrzej Grzegrzolka
- Mateusz Olbromski
- Agnieszka Gomulkiewicz
- Aleksandra Piotrowska
- Natalia Glatzel‑Plucinska
- Katarzyna Ratajczak
- Patrycja Sputa‑Grzegrzolka
- Adam Rzechonek
- Bozena Werynska
- Marzena Podhorska‑Okolow
- Piotr Dziegiel
View Affiliations

Affiliations: Department of Histology and Embryology, Wroclaw Medical University, 50‑368 Wroclaw, Poland, Department of Anatomy, Wroclaw Medical University, 50‑368 Wroclaw, Poland, Department of Thoracic Surgery, Wroclaw Medical University, 50‑368 Wroclaw, Poland, Department of Pulmonology and Lung Cancer, Wroclaw Medical University, 50‑368 Wroclaw, Poland, Division of Ultrastructure Research, Wroclaw Medical University, 50‑368 Wroclaw, Poland
Published online on: November 17, 2020 https://doi.org/10.3892/ol.2020.12309
Article Number: 48
Copyright: © Grzegrzolka et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Non‑small cell lung cancer (NSCLC) is the most commonly diagnosed cancer and the most frequent cause of cancer‑associated mortality worldwide. Tesmin (MTL5) is a 60 kDa protein which has cysteine rich motifs, characteristic of metallothioneins. Tesmin expression was first observed in germ cells during spermatogenesis. Increased tesmin expression in NSCLC has been described previously. Minichromosome maintenance proteins (MCMs) serve a critical role in replication and cell cycle progression, i.e. in NSCLC. The aim of the present study was to evaluate the localization and intensity of tesmin, MCM5 and MCM7 protein expression in NSCLC and their association with the clinicopathological data of patients. Archival paraffin blocks of 243 cases of NSCLC and 104 non‑cancerous tissue samples from the surgical margin (control) were obtained from patients treated at the Clinic of Thoracic Surgery of Wroclaw Medical University (Wroclaw, Poland) between 2010 and 2016, and were used for tissue microarrays and immunohistochemical (IHC) experiments. Laser capture microdissection was used for the isolation of cancer cells from 36 frozen samples of NSCLC and 8 control samples, and subsequently, MTL5, MCM5 and MCM7 mRNA expression was detected separately by reverse transcription‑quantitative PCR. Positive cytoplasmic and nuclear tesmin, as well as nuclear MCM5 and MCM7 IHC expression were observed in 95.1, 83.67, 95.51 and 100% of the NSCLC cases, respectively. MTL5, MCM5 and MCM7 mRNA expression was observed in 91.66% of the cancer cases for all genes. The statistical analysis revealed increased tesmin IHC expression in cancer cells compared with the control. A positive correlation was observed between the IHC expression of nuclear tesmin and MCM5 proteins (r=0.33; P<0.0001) and nuclear tesmin and MCM7 proteins (r=0.315; P<0.0001). In addition, a positive correlation between the mRNA expression levels of MTL5 and MCM5 (r=0.421; P<0.05), MTL5 and MCM7 (r=0.557; P<0.01) was demonstrated. The survival analysis revealed that the presence of IHC cytoplasmic tesmin expression was a positive prognostic marker in NSCLC (P=0.0524). Furthermore, in vitro experiments performed on the NCI‑H1703 cell line revealed that silencing of MTL5 mRNA and tesmin caused the downregulation of the expression levels of MCM5 and MCM7 and decreased the number of cells in the G2 phase. A positive association among tesmin, MCM5 and MCM7 could indicate a possible role of tesmin in the proliferation of NSCLC cancer cells.

View Figures

View References

1	Brambilla E and Travis WD: Lung cancer. Word Cancer Report 2014. Stewart BW and Wild CP: World Health Organization; Lyon: pp. 350–361. 2014
2	Ettinger DS, Akerley W, Bepler G, Blum MG, Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Ganti AK, et al NCCN non-small cell lung cancer panel members, : Non-small cell lung cancer. J Natl Compr Canc Netw. 8:740–801. 2010. View Article : Google Scholar : PubMed/NCBI
3	Camidge DR, Dziadziuszko R, Peters S, Mok T, Noe J, Nowicka M, Gadgeel SM, Cheema P, Pavlakis N, de Marinis F, et al: Updated efficacy and safety data and impact of the EML4-ALK fusion variant on the efficacy of alectinib in untreated ALK-positive advanced non-small cell lung cancer in the global phase III ALEX study. J Thorac Oncol. 14:1233–1243. 2019. View Article : Google Scholar : PubMed/NCBI
4	Sutou S, Miwa K, Matsuura T, Kawasaki Y, Ohinata Y and Mitsui Y: Native tesmin is a 60-kilodalton protein that undergoes dynamic changes in its localization during spermatogenesis in mice. Biol Reprod. 68:1861–1869. 2003. View Article : Google Scholar : PubMed/NCBI
5	HUGO Gene Nomenclature Committee. simplehttp://www.genenames.orgMay 30–2020
6	Grzegrzółka J, Podhorska-Okołów M, Krawczuk Z and Dzięgiel P: The role of tesmin in the physiology and pathogenesis of human diseases. Postepy Hig Med Dosw. 73:762–767. 2019. View Article : Google Scholar
7	Matsuura T, Kawasaki Y, Miwa K, Sutou S, Ohinata Y, Yoshida F and Mitsui Y: Germ cell-specific nucleocytoplasmic shuttling protein, tesmin, responsive to heavy metal stress in mouse testes. J Inorg Biochem. 88:183–191. 2002. View Article : Google Scholar : PubMed/NCBI
8	Olesen C, Møller M and Byskov AG: Tesmin transcription is regulated differently during male and female meiosis. Mol Reprod Dev. 67:116–126. 2004. View Article : Google Scholar : PubMed/NCBI
9	Coyle P, Philcox JC, Carey LC and Rofe AM: Metallothionein: The multipurpose protein. Cell Mol Life Sci. 59:627–647. 2002. View Article : Google Scholar : PubMed/NCBI
10	Maremanda KP, Khan S and Jena G: Zinc protects cyclophosphamide-induced testicular damage in rat: Involvement of metallothionein, tesmin and Nrf2. Biochem Biophys Res Commun. 445:591–596. 2014. View Article : Google Scholar : PubMed/NCBI
11	Oh JH, Yang JO, Hahn Y, Kim MR, Byun SS, Jeon YJ, Kim JM, Song KS, Noh SM, Kim S, et al: Transcriptome analysis of human gastric cancer. Mamm Genome. 16:942–954. 2005. View Article : Google Scholar : PubMed/NCBI
12	Fic M, Pula B, Rogala K and Dziegiel P: Role of metallothionein expression in gastrointestinal cancers. Postepy Biol Komorki. 40:5–20. 2013.
13	Grzegrzolka J, Gomulkiewicz A, Olbromski M, Glatzel-Plucinska N, Piotrowska A, Ratajczak-Wielgomas K, Rzechonek A, Podhorska-Okolow M, Krawczuk Z and Dziegiel P: Expression of tesmin (MTL5) in non small cell lung cancer: A preliminary study. Oncol Rep. 42:253–262. 2019.PubMed/NCBI
14	Jankowska-Konsur A, Kobierzycki C, Reich A, Grzegrzolka J, Maj J and Dziegiel P: Expression of MCM-3 and MCM-7 in primary cutaneous T-cell lymphomas. Anticancer Res. 35:6017–6026. 2015.PubMed/NCBI
15	Yu S, Wang G, Shi Y, Xu H, Zheng Y and Chen Y: MCMs in Cancer: Prognostic Potential and Mechanisms. Anal Cell Pathol (Amst). 2020:37502942020.PubMed/NCBI
16	Honeycutt KA, Chen Z, Koster MI, Miers M, Nuchtern J, Hicks J, Roop DR and Shohet JM: Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis. Oncogene. 25:4027–4032. 2006. View Article : Google Scholar : PubMed/NCBI
17	Mukherjee G, Muralidhar B, Bafna UD, Laskey RA and Coleman N: MCM immunocytochemistry as a first line cervical screening test in developing countries: A prospective cohort study in a regional cancer centre in India. Br J Cancer. 96:1107–1111. 2007. View Article : Google Scholar : PubMed/NCBI
18	Liu YZ, Wang BS, Jiang YY, Cao J, Hao JJ, Zhang Y, Xu X, Cai Y and Wang MR: MCMs expression in lung cancer: Implication of prognostic significance. J Cancer. 8:3641–3647. 2017. View Article : Google Scholar : PubMed/NCBI
19	Wang H, Zhou C, Su B, Teng G, Zheng Y, Zhou X, Guo L, Xu F and Wang X: MCM7 expression is correlated with histological subtypes of lung adenocarcinoma and predictive of poor prognosis. Int J Clin Exp Pathol. 10:11747–11753. 2017.PubMed/NCBI
20	Kobierzycki C, Pula B, Wojnar A, Podhorska-Okolow M and Dziegiel P: Tissue microarray technique in evaluation of proliferative activity in invasive ductal breast cancer. Anticancer Res. 32:773–777. 2012.PubMed/NCBI
21	Remmele W and Stegner HE: Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe. 8:138–140. 1987.(In German). PubMed/NCBI
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−ΔΔC(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
23	Nowinska K, Jablonska K, Pawelczyk K, Piotrowska A, Partynska A, Gomulkiewicz A, Ciesielska U, Katnik E, Grzegrzolka J, Glatzel-Plucinska N, et al: Expression of Irisin/FNDC5 in Cancer Cells and Stromal Fibroblasts of Non-small Cell Lung Cancer. Cancers (Basel). 11:112019. View Article : Google Scholar
24	Olbromski M, Rzechonek A, Grzegrzolka J, Glatzel-Plucinska N, Chachaj A, Werynska B, Podhorska-Okolow M and Dziegiel P: Influence of miR-7a and miR-24-3p on the SOX18 transcript in lung adenocarcinoma. Oncol Rep. 39:201–208. 2018.PubMed/NCBI
25	Olbromski M, Grzegrzolka J, Jankowska-Konsur A, Witkiewicz W, Podhorska-Okolow M and Dziegiel P: MicroRNAs modulate the expression of the SOX18 transcript in lung squamous cell carcinoma. Oncol Rep. 36:2884–2892. 2016. View Article : Google Scholar : PubMed/NCBI
26	Vidarsdottir H, Tran L, Nodin B, Jirström K, Planck M, Jönsson P, Mattsson JSM, Botling J, Micke P and Brunnström H: Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases. Hum Pathol. 84:221–230. 2019. View Article : Google Scholar : PubMed/NCBI
27	Sanada H, Seki N, Mizuno K, Misono S, Uchida A, Yamada Y, Moriya S, Kikkawa N, Machida K, Kumamoto T, et al: Involvement of dual strands of miR-143 (miR-143-5p and miR-143-3p) and their target oncogenes in the molecular pathogenesis of lung adenocarcinoma. Int J Mol Sci. 20:44822019. View Article : Google Scholar
28	Fuller PJ: Novel interactions of the mineralocorticoid receptor. Mol Cell Endocrinol. 408:33–37. 2015. View Article : Google Scholar : PubMed/NCBI
29	Rogerson FM, Yao YZ, Young MJ and Fuller PJ: Identification and characterization of a ligand-selective mineralocorticoid receptor coactivator. FASEB J. 28:4200–4210. 2014. View Article : Google Scholar : PubMed/NCBI